FORTUNE — On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in Gurgaon, India, 20 miles south of New Delhi. It was so early that he passed gardeners watering impeccable shrubs and cleaners still polishing the lobby’s tile floors. As always, Thakur was punctual and organized. He had a round face and low-key demeanor, with deep-set eyes that gave him a doleful appearance.

His boss, Dr. Rajinder Kumar, Ranbaxy’s head of research and development, had joined the generic-drug company just two months earlier from GlaxoSmithKline, where he had served as global head of psychiatry for clinical research and development. Tall and handsome with elegant manners, Kumar, known as Raj, had a reputation for integrity. Thakur liked and respected him.

Like Kumar, Thakur had left a brand-name pharmaceutical company for Ranbaxy. Thakur, then 35, an American-trained engineer and a naturalized U.S. citizen, had worked at Bristol-Myers Squibb  BMY 1.99%  in New Jersey for 10 years. In 2002 a former mentor recruited him to Ranbaxy by appealing to his native patriotism. So he had moved his wife and baby son to Gurgaon to join India’s largest drugmaker and its first multinational pharmaceutical company.

When he stepped into Kumar’s office that morning, Thakur was surprised by his boss’ appearance. He looked weary and uneasy, his eyes puffy and dark. He had returned the previous day from South Africa, where he had met with government regulators. It was clear that the meeting had not gone well.The two men strolled into the hall to order tea from white-uniformed waiters. As they returned, Kumar said, “We are in big trouble,” and motioned for Thakur to be quiet. Back in his office, Kumar handed him a letter from the World Health Organization. It summarized the results of an inspection that WHO had done at Vimta Laboratories, an Indian company that Ranbaxy hired to administer clinical tests of its AIDS medicine. The inspection had focused on antiretroviral (ARV) drugs that Ranbaxy was selling to the South African government to save the lives of its AIDS-ravaged population.

As Thakur read, his jaw dropped. The WHO had uncovered what seemed to the two men to be astonishing fraud. The Vimta tests appeared to be fabricated. Test results from separate patients, which normally would have differed from one another, were identical, as if xeroxed.

Thakur listened intently. Kumar had not even gotten to the really bad news. On the plane back to India, his traveling companion, another Ranbaxy executive, confided that the problem was not limited to Vimta or to those ARV drugs.

“What do you mean?” asked Thakur, barely able to grasp what Kumar was saying.

The problem, said Kumar, went deeper. He directed Thakur to put aside his other responsibilities and go through the company’s portfolio — ultimately, every drug, every market, every production line — and uncover the truth about Ranbaxy’s testing practicesand where the company’s liabilities lay.

Thakur left Kumar’s office stunned. He returned home that evening to find his 3-year-old son playing on the front lawn. The previous year in India, the boy had developed a serious ear infection. A pediatrician prescribed Ranbaxy’s version of amoxiclav, a powerful antibiotic. For three scary days, his son’s 102° fever persisted, despite the medicine. Finally, the pediatrician changed the prescription to the brand-name antibiotic made by GlaxoSmithKline  GSK 2.72% . Within a day, his fever disappeared. Thakur hadn’t thought about it much before. Now he took the boy in his arms and resolved not to give his family any more Ranbaxy drugs until he knew the truth.

Read more about who knew what and when at Fortune Magazine here


Because of Clinton's impeachment, court findings about his perjury and broader dishonesty, Clinton is not a fit and proper person to be associated with a US charity.   And until 2013 he didn't and couldn't hold an office in the charitable foundation that bore his name, the one that was registered in the United States to raise money for a "presidential library".

That didn't stop the Australian Government signing a useless Memorandum of Understanding with the fraudster in 2006.

Nor did it stop us handing over  around $80M of taxpayer money to the foundation bearing his name.

Nor did it stop this, as DFAT told me in a statement last week:

“Prior to 2013, a small amount of Australian aid money was expended on Ranbaxy pharmaceutical products in Papua New Guinea to support the PNG Government’s health programs.”

Kind regards

Media Liaison Officer

Department of Foreign Affairs and Trade

Ho hum.  A small amount of smoking gun.   Perhaps not so small if it's you or your mum who got the Ranbaxy dodgy drugs.

Clinton has star power.   His name sells.   Politicians of all hues love to be photographed with him.

Here's Alexander Downer after signing the dodgy MOU in 2006.

Screen Shot 2016-03-31 at 12.03.37 am

Here's Julie Bishop re-signing a deal with the CHAI (no, not the de-registered Clinton HIV/AIDS Initiative Inc that we contracted with, this is the all new CHAI, the Clinton Health Access Initiative) in 2013.

Screen Shot 2016-03-30 at 11.21.26 pm

Clinton is a crook, pure and simple.   I've reported on the US court findings here on this website.   I've shown you the emails from US regulators.   What is it with our politicians who are prepared to excuse the inexcusable?


And to my friend from the 1990s, I know my reaction was hopelessly inadequate.   I can only ask forgiveness.   I was just 30.   I was so happy to see you at Broadway looking bright and chipper a couple of years ago mate.   This is for you and B. 

More problems for DFAT and The Clintons over $70M we ...
Feb 29, 2016 - ... ... me of further deficiencies in the MOU between DFAT and the Clinton Foundation.

The various Clinton charitable foundations - you and I have ...
Aug 29, 2015 - Since 2006, Australia has contributed $88 million to CHAI and its sister .... The MOU will see Australia and the William J. Clinton Foundation ...

Foreign Affairs Minister Julie Bishop's department pretends ...
Mar 9, 2016 - ... In what capacity did Bill Clinton sign the 22 February 2006 MOU with the ... Is DFAT satisfied that the Clinton Foundation HIV/Aids Initiative ...

Part Two - The Clinton Foundation's de-registered HIV/Aids ...
Mar 9, 2016 - The approved scope of the Clinton Foundation in 2006 did not extend to ... He said that under the MOU, Australia would work with the Clinton ...

Australian Government grants to the Clinton Foundation ...
Apr 24, 2015 - More soon. AusAID and Clinton Foundation HIV/AIDS CN ID CN60579 Agency Department of... ... Contract Period, 31-Jul-2006 to 30-Sep-2009.

Michael Smith News: February 2016
Feb 28, 2016 - ... So certainly by 22 February 2006 in Sydney, Clinton must have known the MOU was a ...

more articles click here - Michael Smith News
In what capacity did Bill Clinton sign the 22 February 2006 MOU with the ... Under the heading "Australian Aid Funding to the Clinton Foundation" DFAT's ...

Hillary Clinton on telling the truth - Michael Smith News
Feb 20, 2016 - Hillary Clinton on telling the truth ..... The government has not made any formal donation to the Clinton Foundation, but since 2006 it has ...

Plan for today - Michael Smith News
Mar 1, 2016 - The Clinton Foundation and some private businesses were deeply .... of a worthless Memorandum Of Understanding to access $70 millions of ...

Your advice and practical help would be much appreciated ...
9 hours ago - Michael Smith News ... Australia's Department of Foreign Affairs signed an MOU with Bill Clinton under which we agreed to pay The Clinton Foundation$25M++ for it ... In 2002 Clinton starts dealing with RANBAXY generic medicine ... This DFAT evaluation of the Clinton HIV/Aids Initiative Inc in Papua New ...